Core Laboratories N.V.
CLB · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $1 | $1 | $0 | $0 |
| % Growth | 2.8% | 4.1% | 4.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 16.9% | 18.4% | 16.1% | 17.8% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 14% | 13.8% | 12% | 13.6% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 6% | 7.2% | 4% | 4.2% |
| EPS Diluted | 0.66 | 0.77 | 0.42 | 0.42 |
| % Growth | -14.3% | 83.3% | 0% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |